Los Angeles Capital Management LLC bought a new stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) in the third ...

Citigroup initiated coverage on shares of Biogen (NASDAQ:BIIB – Get Free Report) in a report issued on Thursday, MarketBeat ...

Deep-pocketed investors have adopted a bearish approach towards Biogen (NASDAQ:BIIB), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

STROKE Medicine doctor hand working Professional doctor use computer and medical equipment all around, desktop top view Three risk factors make it much more likely a person will suffer a severe ...

THURSDAY, Nov. 14, 2024 (HealthDay News) -- The number of Americans sickened in an E. coli outbreak tied to slivered onions used on McDonald's Quarter Pounders has now risen to 104, U.S. health ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of Biogen Inc (Symbol: BIIB) entered into oversold territory, hitting an RSI reading of 29.8 ...

Biogen and Eisai also touted an increase in prescribers and eligible patients for Leqembi. According to Eisai’s presentation, there are currently 10,000 patients in the U.S. who are eligible for ...

A downtrend has been apparent in Biogen Inc. (BIIB) lately with too much selling pressure. The stock has declined 6.4% over the past four weeks. However, given the fact that it is now in oversold ...

Japanese drugmaker Eisai (OTCPK:ESAIY) (OTCPK:ESALF), Biogen's (NASDAQ:BIIB) partner for intravenous Alzheimer's therapy, Leqembi, has completed the rolling submission of a Biologics License ...